Dual Mass Spectrometry as a Tool to Improve Annotation and Quantification in Targeted Plasma Lipidomics

Applications | 2021 | Agilent TechnologiesInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ
Industries
Clinical Research, Lipidomics
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Identification of Molecular Species of Phospholipids by combination of Neutral Loss Survey and MS3
Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells
Unraveling the Complexity of Lipidomes by Multiple Heart-Cutting Q-TOF LC/MS with the Agilent 1290 Infinity 2D-LC Solution
Rapid Structural Elucidation of Lipids Including C=C Positions Using Dual-Polarity CID/OAD in a Single LC-MS Run